Impact of Medicare Part D medication therapy management programs on medication use in older adults with AD/ADRD: ​Are there disparities by race and gender?

Effective medication therapy for older adults to treat AD/ADRD is limited and older adults are at high risk for medication-related problems resulting in increased hospitalizations, ED visits, and health care costs. Comprehensive medication reviews (CMRs), a required service in Medicare Part D medication therapy management (MTM) programs for eligible beneficiaries, are a potential solution to optimize medication use and reduce adverse events. However, the extent of MTM services eligibility and receipt is unknown in older adults with AD/ADRD. In older adults with AD/ADRD, this pilot study aims to: generate nationally representative estimates of MTM eligibility and CMR receipt; quantify disparities in Medicare Part D MTM eligibility and CMR receipt by race and gender; and identify the impact of a CMR on medication use in patients that receive a CMR and potential heterogeneity of benefit by race and gender.